SlideShare a Scribd company logo
Was your Sex Ed lacking? Find the
      missing chapter with




                            Username:
                            iPROVIBE

More Related Content

Viewers also liked

Masturbation
MasturbationMasturbation
Masturbation
Sami Wilberforce
 
disadvantages of masturbation
disadvantages of masturbationdisadvantages of masturbation
disadvantages of masturbation
Haya Khan
 
Yr 12 christian intro ethics
  Yr 12 christian intro ethics  Yr 12 christian intro ethics
Yr 12 christian intro ethics
Tristan Forsyth
 
Masturbation workshop
Masturbation workshopMasturbation workshop
Masturbation workshop
Ernesto Dominguez
 
Health Benefits of Female Masturbation
Health Benefits of Female MasturbationHealth Benefits of Female Masturbation
Health Benefits of Female Masturbation
Medisys Kart
 
Masturbation
MasturbationMasturbation
Masturbation
Anil Bhadoria
 

Viewers also liked (6)

Masturbation
MasturbationMasturbation
Masturbation
 
disadvantages of masturbation
disadvantages of masturbationdisadvantages of masturbation
disadvantages of masturbation
 
Yr 12 christian intro ethics
  Yr 12 christian intro ethics  Yr 12 christian intro ethics
Yr 12 christian intro ethics
 
Masturbation workshop
Masturbation workshopMasturbation workshop
Masturbation workshop
 
Health Benefits of Female Masturbation
Health Benefits of Female MasturbationHealth Benefits of Female Masturbation
Health Benefits of Female Masturbation
 
Masturbation
MasturbationMasturbation
Masturbation
 

More from iPROVIBE

Msm 2010
Msm 2010Msm 2010
Msm 2010
iPROVIBE
 
Mortality - HIV
Mortality - HIVMortality - HIV
Mortality - HIV
iPROVIBE
 
Method of Collecting HIV Statistics
Method of Collecting HIV StatisticsMethod of Collecting HIV Statistics
Method of Collecting HIV Statistics
iPROVIBE
 
Hiv incidence
Hiv incidenceHiv incidence
Hiv incidence
iPROVIBE
 
HIV US Maps 2010
HIV US Maps 2010HIV US Maps 2010
HIV US Maps 2010
iPROVIBE
 
HIV Injection Drug Users
HIV Injection Drug UsersHIV Injection Drug Users
HIV Injection Drug Users
iPROVIBE
 
Epidemiology of HIV Infection
Epidemiology of HIV InfectionEpidemiology of HIV Infection
Epidemiology of HIV Infection
iPROVIBE
 
AIDS Maps
AIDS MapsAIDS Maps
AIDS Maps
iPROVIBE
 
AIDS Regional
AIDS RegionalAIDS Regional
AIDS Regional
iPROVIBE
 
Adolescents
AdolescentsAdolescents
Adolescents
iPROVIBE
 
2010 HIV Race/Ethnicity Slides
2010 HIV Race/Ethnicity Slides2010 HIV Race/Ethnicity Slides
2010 HIV Race/Ethnicity Slides
iPROVIBE
 
2010 aid strends
2010 aid strends2010 aid strends
2010 aid strends
iPROVIBE
 
2010 Pediatric HIV
2010 Pediatric HIV2010 Pediatric HIV
2010 Pediatric HIV
iPROVIBE
 
Urban and Nonurban Areas - HIV
Urban and Nonurban Areas - HIVUrban and Nonurban Areas - HIV
Urban and Nonurban Areas - HIV
iPROVIBE
 
Molluscum Contagiosum
Molluscum ContagiosumMolluscum Contagiosum
Molluscum Contagiosum
iPROVIBE
 
Lice & Scabies
Lice & ScabiesLice & Scabies
Lice & Scabies
iPROVIBE
 
Lymphogranuloma Venereum - LGV
Lymphogranuloma Venereum - LGVLymphogranuloma Venereum - LGV
Lymphogranuloma Venereum - LGV
iPROVIBE
 
Herpes
HerpesHerpes
Herpes
iPROVIBE
 
Granuloma inguinale
Granuloma inguinaleGranuloma inguinale
Granuloma inguinale
iPROVIBE
 
Gonorrhea
GonorrheaGonorrhea
Gonorrhea
iPROVIBE
 

More from iPROVIBE (20)

Msm 2010
Msm 2010Msm 2010
Msm 2010
 
Mortality - HIV
Mortality - HIVMortality - HIV
Mortality - HIV
 
Method of Collecting HIV Statistics
Method of Collecting HIV StatisticsMethod of Collecting HIV Statistics
Method of Collecting HIV Statistics
 
Hiv incidence
Hiv incidenceHiv incidence
Hiv incidence
 
HIV US Maps 2010
HIV US Maps 2010HIV US Maps 2010
HIV US Maps 2010
 
HIV Injection Drug Users
HIV Injection Drug UsersHIV Injection Drug Users
HIV Injection Drug Users
 
Epidemiology of HIV Infection
Epidemiology of HIV InfectionEpidemiology of HIV Infection
Epidemiology of HIV Infection
 
AIDS Maps
AIDS MapsAIDS Maps
AIDS Maps
 
AIDS Regional
AIDS RegionalAIDS Regional
AIDS Regional
 
Adolescents
AdolescentsAdolescents
Adolescents
 
2010 HIV Race/Ethnicity Slides
2010 HIV Race/Ethnicity Slides2010 HIV Race/Ethnicity Slides
2010 HIV Race/Ethnicity Slides
 
2010 aid strends
2010 aid strends2010 aid strends
2010 aid strends
 
2010 Pediatric HIV
2010 Pediatric HIV2010 Pediatric HIV
2010 Pediatric HIV
 
Urban and Nonurban Areas - HIV
Urban and Nonurban Areas - HIVUrban and Nonurban Areas - HIV
Urban and Nonurban Areas - HIV
 
Molluscum Contagiosum
Molluscum ContagiosumMolluscum Contagiosum
Molluscum Contagiosum
 
Lice & Scabies
Lice & ScabiesLice & Scabies
Lice & Scabies
 
Lymphogranuloma Venereum - LGV
Lymphogranuloma Venereum - LGVLymphogranuloma Venereum - LGV
Lymphogranuloma Venereum - LGV
 
Herpes
HerpesHerpes
Herpes
 
Granuloma inguinale
Granuloma inguinaleGranuloma inguinale
Granuloma inguinale
 
Gonorrhea
GonorrheaGonorrhea
Gonorrhea
 

Recently uploaded

Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 

Recently uploaded (20)

Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 

Women

  • 1.
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18. Was your Sex Ed lacking? Find the missing chapter with Username: iPROVIBE

Editor's Notes

  1. HIV Surveillance in Women   For all slides in this series, the following notes apply:   Estimated numbers and rates of diagnoses of HIV infection are based on data from 46 states and 5 U.S. dependent areas that have had confidential name-based HIV infection reporting for a sufficient length of time (i.e., implemented in area since at least January 2007 and reported to CDC since at least June 2007) to allow for stabilization of data collection and for adjustment of the data in order to monitor trends.   Estimated numbers and rates of AIDS diagnoses are based on data from the 50 states, the District of Columbia, and 6 U.S. dependent areas. For the first time, the Republic of Palau has been included in numbers and rates of AIDS diagnoses, deaths, and persons living with AIDS.   Rates are not calculated by race/ethnicity for the 6 U.S. dependent areas because the U.S. Census Bureau does not collect information from all U.S. dependent areas.   At the time of development of this slide series, complete 2010 census data were not available from the U.S. Census Bureau. Therefore, all U.S. population estimates and denominators used to calculate rates were based on the official postcensus estimates for 2009.
  2. During 2007 though 2010, among females aged 13 years and older, black/African American females accounted for the largest estimated numbers of diagnoses of HIV infection each year in the 46 states and 5 U.S. dependent areas, although the number decreased from 7,033 in 2007 to 6,274 in 2010. White and Hispanic/Latino females had similar numbers of diagnoses of HIV infection each year. In 2010, an estimated 1,820 diagnoses of HIV infection were in Hispanic/Latino females, 1,735 diagnoses were in white females, 137 diagnoses were in Asian females, 133 were in females reporting multiple races, 61 diagnoses were in American Indian/Alaska Native females and 8 diagnoses were in Native Hawaiian/other Pacific Islander females.   The following 46 states have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 (and reporting to CDC since at least June 2007): Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming. The 5 U.S. dependent areas include American Samoa, Guam, the Northern Mariana Islands, Puerto Rico and the U.S. Virgin Islands.   Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.   Hispanics/Latinos can be of any race.
  3. Among adult and adolescent females in the 46 states, the overall rate of diagnosis of HIV infection in 2010 was 8.0 per 100,000 population.   By race/ethnicity, the rate for black/African American females (41.7) was nearly 20 times as high as the rate for white females (2.1) and approximately 4½ times as high as the rate for Hispanic/Latino females (9.2). Relatively few cases were diagnosed among Asian, American Indian/Alaska Native, and Native Hawaiian/other Pacific Islander females and females reporting multiple races, although the rates of diagnoses of HIV infection among females of all these races/ethnicities were higher than that for white females.   The following 46 states have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 (and reporting to CDC since at least June 2007): Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.    Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.   Hispanics/Latinos can be of any race.
  4. The pie chart on the left illustrates the percentage distribution of diagnoses of HIV infection among adult and adolescent females in 2010 by race/ethnicity in the 46 states. The pie chart on the right shows the distribution of the female population of the 46 states in 2010.   In 2010, black/African American females made up 12% of the female population in the 46 states but accounted for an estimated 64% of diagnoses of HIV infection among females. Hispanic/Latino females made up 14% of the female population in the 46 states but accounted for 16% of diagnoses of HIV infection among females. White females made up 68% of the female adult and adolescent population in the 46 states but accounted for 18% of diagnoses of HIV infection among females.   The following 46 states have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 (and reporting to CDC since at least June 2007): Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.    Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.   Hispanics/Latinos can be of any race.
  5. This slide shows the percentage distribution of diagnoses of HIV infection among adult and adolescent black/African American, Hispanic/Latino, and white females by transmission category in the 46 states and 5 dependent areas.   Black/African American and Hispanic/Latino females had similar distributions of diagnosed HIV infections attributed to heterosexual contact (88%) and injection drug use (12%). Meanwhile, percentages among white females were 75% for heterosexual contact and 25% for injection drug use.   The following 46 states have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 (and reporting to CDC since at least June 2007): Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming. The 5 U.S. dependent areas include American Samoa, Guam, the Northern Mariana Islands, Puerto Rico and the U.S. Virgin Islands.   Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting.   Hispanics/Latinos can be of any race.   Heterosexual contact is with a person known to have, or to be at high risk for, HIV infection.
  6. In 2010, the majority of diagnoses of HIV infection among females aged 13 years or older were attributed to heterosexual contact regardless of age group. However, the percentages attributed to heterosexual contact decreased as age group increased. An estimated 18.0% of diagnosed HIV infections among females aged 45 years and older were attributed to injection drug use, compared with 8.0% in females aged 13–19 years, 9.7% in females aged 20–24 years, 12.5% in females aged 25-34 years, and 13.7% in females aged 35-44 years. The following 46 states have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 (and reporting to CDC since at least June 2007): Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming. The 5 U.S. dependent areas include American Samoa, Guam, the Northern Mariana Islands, Puerto Rico and the U.S. Virgin Islands.   Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor information, but not for incomplete reporting.   Heterosexual contact is with a person known to have, or to be at high risk for, HIV infection.
  7. This slide shows rates of diagnoses of HIV infection among adult and adolescent females aged 13 years and older by area of residence at diagnosis. In the 46 states and 5 U.S. dependent areas, the rates ranged from zero per 100,000 population in American Samoa and the Northern Mariana Islands to 18.1 per 100,000 population in Florida, 18.7 in Louisiana, and 40.8 in the U.S. Virgin Islands.    The following 46 states have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 (and reporting to CDC since at least June 2007): Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming. The 5 U.S. dependent areas include American Samoa, Guam, the Northern Mariana Islands, Puerto Rico and the U.S. Virgin Islands.   Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.
  8. This slide shows the estimated numbers and rates of deaths of adult and adolescent females aged 13 years and older with a diagnosis of HIV infection by race/ethnicity in 2009 in 46 states.   The rate of death (per 100,000 population) for black/African American females (23.8) was the highest among all races/ethnicities, and was nearly 22 times as high as the rate of death for whites (1.1) and more than 5 times as high as the rate for Hispanics/Latinos (4.5). Relatively few deaths were among American Indians/Alaska Natives, Asians, and females reporting multiple races, although the rates of death for American Indians/Alaska Natives (2.8), and females reporting multiple races (12.2) were higher than that for white females. The rate for Asian females was 0.4 and the rate for Native Hawaiian/other Pacific Islander females was 1.0.   The following 46 states have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 (and reporting to CDC since at least June 2007): Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.    Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Persons are classified as adult or adolescent based on age at death.   The Asian category includes Asian/Pacific Islander legacy cases (cases that were diagnosed and reported under the old Office of Management and Budget race/ethnicity classification system).   Hispanics/Latinos can be of any race.
  9. This slide shows the estimated rates (per 100,000 population) of adult and adolescent females living with a diagnosis of HIV infection at the end of 2009 in the 46 states and 5 U.S. dependent areas.   Areas with the highest estimated rates were the U.S. Virgin Islands (497.2), New York (464.9), Florida (353.3), Puerto Rico (337.6), and New Jersey, (330.8); however, high rates were evident in the majority of states in the south and those along the East Coast through New York and Connecticut.    The following 46 states have had laws or regulations requiring confidential name-based HIV infection reporting since at least January 2007 (and reporting to CDC since at least June 2007): Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming. The 5 U.S. dependent areas include American Samoa, Guam, the Northern Mariana Islands, Puerto Rico and the U.S. Virgin Islands.   Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Persons living with a diagnosis of HIV infection are classified as adult or adolescent based on age at end of 2009.
  10. Of all AIDS diagnoses from 1985-2010, the estimated percentage among adult and adolescent females increased from 7% in 1985 to 25% in 2010. The numbers of AIDS diagnoses among adult and adolescent females rose steadily from 1985 to 1993, when the AIDS surveillance case definition was expanded, and leveled off at approximately 13,000 AIDS diagnoses each year from 1993 through 1996. In 1996, AIDS diagnoses among females began to decline, primarily because of the success of antiretroviral therapies. In 2010, there were just over 8,400 AIDS diagnoses among females. All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.
  11. This slide shows the numbers of AIDS diagnoses among adult and adolescent females from 1985 through 2010 in the United States and 6 U.S. dependent areas. Black/African American females accounted for the largest estimated numbers of diagnoses of HIV infection each year among females, though the numbers have continually decreased from 7,045 in 2003 to 5,425 in 2010. White and Hispanic/Latino females had similar numbers of AIDS diagnoses each year.   All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.   The Asian category includes Asian/Pacific Islander legacy cases (cases that were diagnosed and reported under the old Office of Management and Budget race/ethnicity classification system).   Hispanics/Latinos can be of any race.
  12. This slide shows the percentages of AIDS diagnoses among adult and adolescent females by race/ethnicity from 1985 through 2010 in the United States and 6 U.S. dependent areas. Among females, the annual percentage of diagnoses has continued to increase among blacks/African Americans, from approximately 52% of diagnoses among females in 1985 to 64% in 2010. White females had a decreasing percentage of AIDS diagnoses through 1996 and the percentages have remained relatively stable since then. The percentage of AIDS diagnoses among Hispanic/Latino females have remained relatively stable (around 20%) since 1985.   All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.   The Asian category includes Asian/Pacific Islander legacy cases (cases that were diagnosed and reported under the old Office of Management and Budget race/ethnicity classification system).   Hispanics/Latinos can be of any race.
  13. In 2010, the estimated rate of AIDS diagnoses among adult and adolescent females in the United States was 6.4 per 100,000 population. The rate of AIDS diagnoses among black/African American females (33.7) was nearly 22½ times as high as the rate for white females (1.5).   The estimated number of AIDS diagnoses among females in 2009 was similar for Hispanics/Latino and white females; however, the rate for Hispanics/Latino females (7.1) was almost 5 times as high as the rate for white females.   Relatively few cases were diagnosed among Asian, American Indian/Alaska Native, Native Hawaiian/Other Pacific Islander females and females reporting multiple races; however, the rates for American Indian/Alaska Native females (4.6), Native Hawaiian/other Pacific Islander females (5.4) and females reporting multiple races (13.1) were higher than the rate for white females. The rate for Asian females was 1.2.   All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.   The Asian category includes Asian/Pacific Islander legacy cases (cases that were diagnosed and reported under the old Office of Management and Budget race/ethnicity classification system).   Hispanics/Latinos can be of any race.
  14. In 2010, the highest percentage of diagnosed AIDS cases for all age groups of adults and adolescent females were attributed to heterosexual contact. However, the percentages attributed to heterosexual contact were higher among females aged 25-34 (83.7%) than among other age groups.   Diagnosed AIDS cases attributed to injection drug use were highest among females aged 45 years and older (26.5%), followed by 20.0% in females aged 35-44, 16.0% in females aged 25-34 years, 12.3% in females aged 20-24 years, and 9.0% in females age 13–19 years. Among females age 13-19 years, 37.5% of diagnosed infections were attributed to “other” transmission categories, the majority of which were perinatal exposures.   All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing risk-factor, but not for incomplete reporting.   Heterosexual contact is with a person known to have, or to be at high risk for, HIV infection.
  15. This slide presents the estimated rates of AIDS diagnoses (per 100,000 population) in 2010 among adult and adolescent black/African American, Hispanic/Latino and white females by region of residence in the United States. Most AIDS diagnoses among adult and adolescent females were among those who resided in the Northeast and the South.   The highest rates of AIDS diagnoses were among black/African American females in the Northeast (50.1) and in the South (34.9).   The highest rate of AIDS diagnoses among Hispanic/Latino females was in the Northeast (23.1).   Data are not shown for Asian, American Indian/Alaska Native and Native Hawaiian/other Pacific Islander females or females reporting multiple races because the estimated numbers when stratified by region of residence are small.   Regions of residence are defined as follows:   Northeast—Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont Midwest—Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, Wisconsin South—Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, West Virginia West—Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, Wyoming   All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.   Hispanics/Latinos can be of any race.
  16. Estimated rates of AIDS diagnoses (per 100,000 population) among adult and adolescent females during 2010 are shown for each state, the District of Columbia, and for 6 U.S. dependent areas. The highest rates were in the District of Columbia (79.9), Maryland (18.5), and Louisiana (15.5), followed by Florida (14.7), the U.S. Virgin Islands (14.3), New York (14.1), New Jersey (11.6), Delaware (10.9), and Mississippi (10.3).   The District of Columbia is a metropolitan area; use caution when comparing the estimated rate of AIDS diagnoses in the District of Columbia to the rates in states. All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.
  17. This slide shows the estimated rates (per 100,000 population) of adult and adolescent females living with an AIDS diagnosis at the end of 2009 in the United States and dependent areas.   Areas with the highest estimated rates of females living with an AIDS diagnosis were the District of Columbia (868.4), New York (280.2), Maryland (246.4), the U.S. Virgin Islands (242.0), Puerto Rico (191.1), Florida (188.1), New Jersey (169.0), and Delaware (154.0).   The District of Columbia is a metropolitan area; use caution when comparing the estimated rate of AIDS diagnoses in the District of Columbia to the rates in states.   All displayed data are estimates. Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Persons living with an AIDS diagnosis are classified as adult or adolescent based on age at end of 2009.